Karin Nelander

Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism

Sven Nylander, Eti Alessandra Femia, Mariangela Scavone et al. · Journal of Thrombosis and Haemostasis · 2013 · 148 citations · Full text

Thrombopoiesis, Thrombosis, Signal Transduction +11

Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly Reduced Ejection Fraction: SATELLITE Trial Results

Carolyn S.P. Lam, Lars H. Lund, Sanjiv J. Shah et al. · Journal of Cardiac Failure · 2023 · 60 citations · Full text

Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction

Karin Nelander, Maria Lagerström‐Fermér, Carl Amilon et al. · Clinical and Translational Science · 2020 · 44 citations · Full text

Heart Failure, Healthy Subjects, Cardiovascular Pharmacology +16

Rationale and Design of ENDEAVOR: A Sequential Phase 2b–3 Randomized Clinical Trial to Evaluate the Effect of Myeloperoxidase Inhibition on Symptoms and Exercise Capacity in Heart Failure with Preserved or Mildly Reduced Ejection Fraction

Lars H. Lund, Carolyn S.P. Lam, Patricia Ely Pizzato et al. · European Journal of Heart Failure · 2023 · 41 citations · Full text

Safety, tolerability, pharmacokinetics and effect on serum uric acid of the myeloperoxidase inhibitor AZD4831 in a randomized, placebo‐controlled, phase I study in healthy volunteers

Li‐Ming Gan, Maria Lagerström‐Fermér, Hans Ericsson et al. · British Journal of Clinical Pharmacology · 2019 · 38 citations · Full text